🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-526090-42-00
Completed Phase I

A study to test how well different and multiple doses of BI 3034701 are tolerated in people living with overweight or obesity

2026-526090-42-00 · tracked via the Priya Life Science EU tracker
Sponsor
Boehringer Ingelheim International GmbH
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
18/08/2026
Enrollment target
35
Sites
Germany

Condition studied

overweight, obesity

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-526090-42-00 on CTIS ↗ ← All trials in the EU